Imperial College London

ProfessorJenniferQuint

Faculty of MedicineSchool of Public Health

Professor of Respiratory Epidemiology
 
 
 
//

Contact

 

+44 (0)20 7594 8821j.quint

 
 
//

Location

 

.922Sir Michael Uren HubWhite City Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Gayle:2019:10.1136/thoraxjnl-2018-212514,
author = {Gayle, A and Axson, E and Bloom, C and Navaratnam, V and Quint, J},
doi = {10.1136/thoraxjnl-2018-212514},
journal = {Thorax},
pages = {483--491},
title = {Changing causes of death for patients with chronic respiratory disease in England, 2005-2015},
url = {http://dx.doi.org/10.1136/thoraxjnl-2018-212514},
volume = {74},
year = {2019}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AB - Background Chronic respiratory diseases (CRD) are common, are increasing in prevalence, and cause significant morbidity and mortality worldwide. However, we have limited knowledge on causes of death of patients with CRD in the general population.Objective We evaluated mortality rates and causes of death over time in patients with CRD.Methods We used linked primary care and mortality data to determine mortality rates and the most common causes of death in people with CRD (including asthma, bronchiectasis, COPD and interstitial lung diseases (ILD)) during 2005–2015 in England.Results We identified 558 888 patients with CRD (451 830 asthma, 137 709 COPD, 19 374 bronchiectasis, 10 745 ILD). The age-standardised mortality rate of patients with CRD was 1607 per 100 000 persons (asthma=856, COPD=1503, ILD=2609, bronchiectasis=1463). CRD mortality was overall 54% higher than the general population. A third of patients with CRD died from respiratory-related causes. Respiratory-related mortality was constant, while cardiovascular-related mortality decreased significantly over time. COPD accounted for the majority of respiratory-related deaths (66% overall) in all patient groups except ILD.Conclusions Patients with CRD continue to experience substantial morbidity and mortality due to respiratory diseases. Disease-modifying intervention strategies are needed to improve outcomes for patients with CRD.
AU - Gayle,A
AU - Axson,E
AU - Bloom,C
AU - Navaratnam,V
AU - Quint,J
DO - 10.1136/thoraxjnl-2018-212514
EP - 491
PY - 2019///
SN - 1468-3296
SP - 483
TI - Changing causes of death for patients with chronic respiratory disease in England, 2005-2015
T2 - Thorax
UR - http://dx.doi.org/10.1136/thoraxjnl-2018-212514
UR - http://hdl.handle.net/10044/1/66909
VL - 74
ER -